Dr Reddys Laboratories (RDY) Receivables - Net (2017 - 2026)
Dr Reddys Laboratories has reported Receivables - Net over the past 10 years, most recently at $1.1 billion for Q1 2026.
- For Q1 2026, Receivables - Net rose 1032.43% year-over-year to $1.1 billion; the TTM value through Mar 2026 reached $1.1 billion, up 1032.43%, while the annual FY2026 figure was $1.1 billion, 4.66% up from the prior year.
- Receivables - Net for Q1 2026 was $1.1 billion at Dr Reddys Laboratories, up from -$118.7 million in the prior quarter.
- Over five years, Receivables - Net peaked at $1.1 billion in Q1 2026 and troughed at -$118.7 million in Q1 2025.
- A 5-year average of $745.2 million and a median of $888.6 million in 2022 define the central range for Receivables - Net.
- Biggest five-year swings in Receivables - Net: plummeted 112.28% in 2025 and later skyrocketed 1032.43% in 2026.
- Year by year, Receivables - Net stood at $888.6 million in 2022, then dropped by 0.77% to $881.8 million in 2023, then rose by 9.66% to $966.9 million in 2024, then plummeted by 112.28% to -$118.7 million in 2025, then skyrocketed by 1032.43% to $1.1 billion in 2026.
- Business Quant data shows Receivables - Net for RDY at $1.1 billion in Q1 2026, -$118.7 million in Q1 2025, and $966.9 million in Q1 2024.